Basic Information
RheumaGen is a private biotechnology company dedicated to developing a new class of therapies to treat major autoimmune diseases. RheumaGen focuses on editing human leukocyte antigen (HLA) or "immune genes" to develop one-time curative cell and gene therapies.
RheumaGen, Inc.
Aurora,Colorado,United States of America
less than 15 people
January 01, 2019
info@rheumagen.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios